A protest over a draft decision not to recommend a new cystic fibrosis drug is due later. Campaigners keen to see Kalydeco introduced across Wales are aiming to make their voices heard outside a meeting of the All Wales Medicines Strategy Group at the Angel Hotel in Abergavenny.
The group will look at the recommendation and decide whether to approve it or not. The drug - which is already available in England, Scotland and Northern Ireland - is the first licensed drug that treats the G551D mutation - the fundamental defect in those with cystic fibrosis.
More top news
A former asylum seeker and tennis player from Swansea has won a sports award as part of Black History Month.
A mostly dry day with a little light rain or drizzle over hills.
Welsh Government figures show a sharp rise in the number of Section 31 court orders removing children from parents.